Devyser Diagnostics AB (DVYSR) - Total Liabilities

Latest as of September 2025: Skr119.00 Million SEK ≈ $12.81 Million USD

Based on the latest financial reports, Devyser Diagnostics AB (DVYSR) has total liabilities worth Skr119.00 Million SEK (≈ $12.81 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Devyser Diagnostics AB operating cash flow efficiency to assess how effectively this company generates cash.

Devyser Diagnostics AB - Total Liabilities Trend (2018–2024)

This chart illustrates how Devyser Diagnostics AB's total liabilities have evolved over time, based on quarterly financial data. Check asset resilience ratio of Devyser Diagnostics AB to evaluate the company's liquid asset resilience ratio.

Devyser Diagnostics AB Competitors by Total Liabilities

The table below lists competitors of Devyser Diagnostics AB ranked by their total liabilities.

Company	Country	Total Liabilities
Titan Minerals Ltd AU:TTM	Australia	AU$3.36 Million
Groupe Partouche SA PA:PARP	France	€572.21 Million
TK Chemical Corporation KQ:104480	Korea	₩236.98 Billion
Syscom Computer Engineering Co TW:2453	Taiwan	NT$2.76 Billion
Hainan Meilan International Airport Company Limited F:HAO	Germany	€6.62 Billion
Duxton Water Ltd AU:D2O	Australia	AU$20.63 Million
Range Capital Acquisition Corp. Ordinary Shares NASDAQ:RANG	USA	$203.54K
Thai Nakarin Hospital Public Company Limited BK:TNH	Thailand	฿563.40 Million

Liability Composition Analysis (2018–2024)

This chart breaks down Devyser Diagnostics AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Devyser Diagnostics AB (DVYSR) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.78	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.35	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.26	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Devyser Diagnostics AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Devyser Diagnostics AB (2018–2024)

The table below shows the annual total liabilities of Devyser Diagnostics AB from 2018 to 2024.

Year	Total Liabilities	Change
2024-12-31	Skr124.80 Million ≈ $13.43 Million	-0.16%
2023-12-31	Skr125.00 Million ≈ $13.45 Million	+80.66%
2022-12-31	Skr69.19 Million ≈ $7.45 Million	+72.19%
2021-12-31	Skr40.18 Million ≈ $4.32 Million	-7.80%
2020-12-31	Skr43.58 Million ≈ $4.69 Million	+18.78%
2019-12-31	Skr36.69 Million ≈ $3.95 Million	+101.02%
2018-12-31	Skr18.25 Million ≈ $1.96 Million	--

About Devyser Diagnostics AB

ST:DVYSR Sweden Diagnostics & Research

Market Cap

$168.47 Million

Skr1.57 Billion SEK

Market Cap Rank

#17177 Global

#285 in Sweden

Share Price

Skr94.00

Change (1 day)

-0.95%

52-Week Range

Skr74.40 - Skr157.80

All Time High

Skr157.80